This suggested that patients with moderate to strong NuMA immunostaining at the spindle poles in primary cultures have a lower survival rate than patients with weak NuMA immunostaining, though this preliminary data did not reach statistical significance ( Figure S4 ), perhaps due to low sample size.
1
—
—